LENSAR, Inc. (NASDAQ:LNSR) Short Interest Down 27.0% in May

LENSAR, Inc. (NASDAQ:LNSR - Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 107,500 shares, a decline of 27.0% from the April 30th total of 147,200 shares. Based on an average daily trading volume, of 180,900 shares, the short-interest ratio is presently 0.6 days. Currently, 1.1% of the company's stock are sold short.

Analyst Upgrades and Downgrades

LNSR has been the topic of several recent research reports. BTIG Research lowered LENSAR from a "strong-buy" rating to a "hold" rating in a report on Monday, March 24th. Lake Street Capital reaffirmed a "hold" rating and set a $15.00 target price (down from $16.00) on shares of LENSAR in a research report on Monday, March 24th.

LENSAR Stock Performance

Shares of LENSAR stock traded up $0.03 during trading hours on Tuesday, reaching $13.55. The company's stock had a trading volume of 44,379 shares, compared to its average volume of 79,363. The company has a market capitalization of $159.78 million, a P/E ratio of -9.28 and a beta of 0.56. The stock's fifty day simple moving average is $13.84 and its two-hundred day simple moving average is $11.36. LENSAR has a one year low of $3.50 and a one year high of $17.31.

LENSAR (NASDAQ:LNSR - Get Free Report) last announced its quarterly earnings results on Thursday, May 8th. The company reported ($2.32) earnings per share for the quarter, missing the consensus estimate of ($0.16) by ($2.16). The business had revenue of $11.53 million during the quarter, compared to the consensus estimate of $13.40 million. LENSAR had a negative net margin of 34.03% and a negative return on equity of 49.02%.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of LNSR. Geode Capital Management LLC lifted its stake in LENSAR by 5.6% during the 4th quarter. Geode Capital Management LLC now owns 106,058 shares of the company's stock valued at $948,000 after acquiring an additional 5,627 shares in the last quarter. Atria Investments Inc raised its holdings in shares of LENSAR by 28.2% in the fourth quarter. Atria Investments Inc now owns 26,055 shares of the company's stock valued at $233,000 after purchasing an additional 5,729 shares during the last quarter. Brandes Investment Partners LP lifted its position in shares of LENSAR by 10.4% during the fourth quarter. Brandes Investment Partners LP now owns 489,318 shares of the company's stock valued at $4,375,000 after purchasing an additional 45,920 shares in the last quarter. Renaissance Technologies LLC boosted its holdings in LENSAR by 13.3% during the fourth quarter. Renaissance Technologies LLC now owns 348,891 shares of the company's stock worth $3,119,000 after purchasing an additional 40,946 shares during the last quarter. Finally, Essex Investment Management Co. LLC boosted its holdings in LENSAR by 18.3% during the fourth quarter. Essex Investment Management Co. LLC now owns 39,890 shares of the company's stock worth $357,000 after purchasing an additional 6,184 shares during the last quarter. Hedge funds and other institutional investors own 40.15% of the company's stock.

About LENSAR

LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. It offers LENSAR Laser System that incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.